Most Likely Diagnosis: Anti-RNP Autoimmune Myositis with Possible CNS Involvement
Based on your positive anti-RNP antibodies (4.7, reference 0-0.9), progressive proximal muscle weakness, mildly elevated CK (371), and MRI findings showing nonspecific T2 hyperintensity in the cervical spinal cord and cerebellar white matter, you most likely have anti-U1-RNP-associated myositis—a distinct autoimmune inflammatory myopathy—not ALS.
Why This Is NOT ALS
Your presentation argues strongly against amyotrophic lateral sclerosis:
- Age: At 29, you are far too young for typical ALS (median onset 55-65 years)
- Positive autoantibodies: ALS does not cause anti-RNP positivity or elevated ANA
- Normal/low inflammatory markers: Your ESR of 2 and CRP of 3.3 are essentially normal, but this doesn't exclude autoimmune myositis 1
- Seasonal pattern: Your recurrent weakness from specific months suggests environmental/immune triggers, not neurodegenerative disease
- Recovery potential: ALS is relentlessly progressive without remission; autoimmune myositis responds to treatment
Understanding Your Diagnosis
Anti-U1-RNP Myositis Phenotype
You fit the classic profile described in the literature 1:
- Demographics: Young (you're 29; typical onset ~37 years), Black male (60% of anti-RNP myositis patients are Black)
- Muscle involvement: Progressive proximal weakness in thighs, arms, shoulders, fingers, wrists—exactly matching the distribution
- Mildly elevated CK: Your CK of 371 (just above 366 upper limit) is typical; anti-RNP myositis often has less dramatic CK elevation than other myositis subtypes
- Muscle biopsy pattern: When biopsied, 4 of 7 anti-RNP patients showed necrotizing changes 1
Your Extramuscular Features
Anti-RNP myositis is a systemic disease with multiple organ involvement 1:
- Recurrent infections (adenotonsillitis, sinus infections): Immune dysregulation increases infection susceptibility
- Joint symptoms: Hip pain and morning stiffness suggest arthritis, present in 60% of anti-RNP patients 1
- Potential lung involvement: 45% develop interstitial lung disease—your sleep study will help assess this 1
- CNS findings: The T2 hyperintensities in your cervical cord and cerebellum are "nonspecific but may be seen in autoimmune disorders or demyelination" per your radiology report
Critical Distinction: This Is Not Just "Seasonal Allergies"
Your seasonal pattern (weakness from specific months yearly) suggests:
- Environmental triggers activating underlying autoimmune disease
- Vitamin D fluctuation (yours is adequate at 75, but seasonal variation may occur)
- Infection clustering during certain seasons triggering immune flares
Immediate Diagnostic Workup Needed
Based on myositis guidelines 2, 3, 4, your rheumatologist should order:
Blood Tests
- Myositis-specific antibodies panel: Anti-Jo-1 was negative, but test for anti-Ro52 (present in 25-40% with pericarditis/glomerulonephritis in anti-RNP patients) 1
- Aldolase and LDH: Additional muscle enzyme markers 3
- Troponin and BNP: Cardiac involvement screening 3
- Repeat CK: For trend monitoring
Imaging
- Muscle MRI of thighs: T2-weighted with STIR sequences to identify inflammation and guide biopsy site 4
- Brain MRI with contrast: Your radiologist specifically recommended this to evaluate the cord/cerebellar T2 changes 5
- Chest CT: To screen for interstitial lung disease (45% risk) 1
- Echocardiogram: Pericarditis occurs in 40% of anti-RNP patients 1
Tissue Diagnosis
- Muscle biopsy: From an inflamed area identified on MRI, looking for necrotizing myopathy or inflammatory infiltrates 3, 4
- EMG: To document myopathic changes and exclude neurogenic causes 3
Treatment Plan
First-Line Therapy
You will need immunosuppression, not just supportive care. Based on inflammatory myopathy guidelines 4:
Initial regimen:
- Prednisone 1 mg/kg/day (approximately 140 mg for your 318 lb weight) 4
- PLUS a steroid-sparing agent started simultaneously 4:
- Methotrexate 15-25 mg weekly (oral or subcutaneous), OR
- Azathioprine 2-3 mg/kg/day, OR
- Mycophenolate mofetil 2-3 g/day
Why start both together? Starting a steroid-sparing agent immediately allows faster corticosteroid taper and reduces long-term steroid toxicity 4.
If Severe or Refractory
Given your progressive weakness and CNS involvement, if you don't respond within 4-6 weeks 2:
- IV methylprednisolone 1 g/day × 3-5 days 3
- IVIG 2 g/kg divided over 2-5 days 3
- Consider rituximab (375 mg/m² weekly × 4 doses) for refractory cases 3
Monitoring Response
Track these parameters every 2-4 weeks initially 3:
- Clinical: Muscle strength testing (quantified), ability to rise from chair, lift arms
- Laboratory: CK, aldolase, ESR, CRP
- Imaging: Repeat muscle MRI at 3-6 months
Prognosis and Recovery
Good News
You can recover from this. Anti-RNP myositis responds to immunosuppression 1:
- No mortality was reported in the anti-RNP cohort during follow-up 1
- No cancer association: Unlike other myositis subtypes, anti-RNP myositis is not paraneoplastic 1
- 80% eventually develop weakness, but this implies 20% have mild or controlled disease 1
Realistic Expectations
- Treatment duration: Expect 1-2 years of immunosuppression minimum
- Steroid taper: Very gradual over 6-12 months to prevent relapse
- Maintenance therapy: May need long-term low-dose immunosuppression
- Relapses: Can occur, especially if steroids tapered too quickly
Rebuilding Muscle
Your concern about not rebuilding muscle is valid:
- During active inflammation: Avoid aggressive strengthening; inflammation damages muscle faster than you can build it
- After disease control (CK normalizing, strength stabilizing): Begin supervised physical therapy with gradual progressive resistance
- Weight management: At 318 lb and 6'5", losing weight will reduce mechanical stress on inflamed muscles and improve treatment response
Addressing Your Specific Concerns
Muscle Twitching (Fasciculations)
Your twitching is likely benign fasciculations from:
- Anxiety (which you acknowledge)
- Electrolyte shifts (your creatinine fluctuations suggest hydration issues)
- Muscle irritability from inflammation
This is NOT the fasciculations of ALS, which are accompanied by atrophy, hyperreflexia, and relentless progression.
Cramping and Soreness
This represents active muscle inflammation, not deconditioning. You cannot "work through" inflammatory myositis—exercise during active disease worsens damage.
Elevated Homocysteine (21.6)
Your elevated homocysteine despite adequate B12 (705) and folate (6.3) may reflect:
- MTHFR polymorphism: Common in autoimmune disease
- Increased thrombosis risk: Relevant given your anti-RNP status
- Treatment: Consider methylfolate supplementation and discuss aspirin with your rheumatologist
Fluctuating Creatinine (1.12-1.33)
This mild fluctuation likely reflects:
- Hydration status: You're a large man; ensure 3-4 liters daily
- Muscle breakdown: Myoglobin can affect kidney function
- Monitor closely: Rhabdomyolysis risk if CK rises dramatically
Critical Next Steps
Before Your Appointments
Document daily:
- Muscle strength (can you rise from chair without hands? lift arms overhead?)
- Pain severity (0-10 scale)
- New symptoms
Prepare questions for rheumatologist:
- "Do I need a muscle biopsy?"
- "When will we start immunosuppression?"
- "What's the plan if I don't respond to first-line therapy?"
Cardiac screening: Request echocardiogram before starting treatment
Red Flags Requiring ER Visit
Go immediately if you develop:
- Chest pain or palpitations: Pericarditis/myocarditis risk
- Severe shortness of breath: Pulmonary involvement
- Dark brown urine with rising CK: Rhabdomyolysis
- Difficulty swallowing: Pharyngeal muscle involvement
- Fever >101°F: Infection risk with immune dysregulation
Why the Delay in Diagnosis?
Your case illustrates common pitfalls:
- Anti-RNP myositis is rare: Many clinicians unfamiliar with this phenotype
- Normal ESR/CRP: Doesn't exclude autoimmune myositis 1
- Mild CK elevation: Can be overlooked as "nonspecific"
- Young age: Myositis often considered a disease of older adults
- Recurrent infections: May have distracted from underlying autoimmune process
Bottom Line
You have a treatable autoimmune condition, not a fatal neurodegenerative disease. Your anti-RNP antibodies, clinical phenotype, and MRI findings point to anti-U1-RNP-associated myositis with possible CNS involvement. With prompt immunosuppression, you should see improvement within weeks to months. The key is starting treatment quickly—delays beyond 2 weeks worsen outcomes 5. Push your rheumatologist for urgent initiation of therapy while awaiting confirmatory muscle biopsy results.